Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma

BACKGROUND: Dysregulation of immune checkpoint molecules leads to immune evasion in human tumours but has become a viable target for tumour therapy. Here, we examined expression of Herpes virus entry mediator (HVEM), an immune checkpoint molecule, in human glioblastoma (GBM) to assess its potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Ming-Zhi, Wang, Shuai, Zhao, Wen-Bo, Ni, Shi-Lei, Yang, Ning, Kong, Yang, Huang, Bin, Chen, An-Jing, Li, Xin-Gang, Wang, Jian, Wang, Dong-Hai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557785/
https://www.ncbi.nlm.nih.gov/pubmed/30987862
http://dx.doi.org/10.1016/j.ebiom.2019.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557785/
https://www.ncbi.nlm.nih.gov/pubmed/30987862
http://dx.doi.org/10.1016/j.ebiom.2019.04.002

Ejemplares similares